Utility and validity of DISC1 mouse models in biological psychiatry

Neuroscience

Volumn 321, Issue , 2016, Pages 99-107

  Tomoda, T ^a   Sumitomo, A ^a   Jaaro Peled, H ^b   Sawa, A ^b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DISC1; Mouse models; Psychiatry

Indexed keywords

DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DISC1 PROTEIN, MOUSE; NERVE PROTEIN;

DIAGNOSTIC VALUE; DISC1 GENE; HAPLOINSUFFICIENCY; HOST; HOST ENVIRONMENT INTERACTION; MOUSE MODEL; NERVE CELL DIFFERENTIATION; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PSYCHIATRY; REVIEW; SYNAPTIC INHIBITION; TRANSGENIC MOUSE; VALIDITY; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; MENTAL DISEASE; METABOLISM; MUTANT MOUSE STRAIN; PATHOPHYSIOLOGY; TRANSLATIONAL RESEARCH;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MENTAL DISORDERS; MICE, MUTANT STRAINS; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84956494037     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.12.061     Document Type: Review

References (92)

1. Abazyan B., Nomura J., Kannan G., Ishizuka K., Tamashiro K.L., Nucifora F., Pogorelov V., Ladenheim B., Yang C., Krasnova I.N., Cadet J.L., Pardo C., Mori S., Kamiya A., Vogel M.W., Sawa A., Ross C.A., Pletnikov M.V. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 2010, 68:1172-1181.
2. Abazyan B., Dziedzic J., Hua K., Abazyan S., Yang C., Mori S., Pletnikov M.V., Guilarte T.R. Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study. Schizophr Bull 2014, 40:575-584.
3. Abazyan S., Yang E.J., Abazyan B., Xia M., Yang C., Rojas C., Slusher B., Sattler R., Pletnikov M. Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism. J Neurosci Res 2014, 92:1659-1668.
4. Andréasson S., Allebeck P., Engström A., Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987, 2:1483-1486.
5. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T.E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002, 325:1212-1213.
6. Atkin T.A., Brandon N.J., Kittler J.T. Disrupted in Schizophrenia 1 forms pathological aggresomes that disrupt its function in intracellular transport. Hum Mol Genet 2012, 21:2017-2028.
7. Ballinger M.D., Saito A., Abazyan B., Taniguchi Y., Huang C.H., Ito K., Zhu X., Segal H., Jaaro-Peled H., Sawa A., Mackie K., Pletnikov M.V., Kamiya A. Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory. Neurobiol of Disease 2015, 82:176-184.
8. Blackwood D.H., Fordyce A., Walker M.T., St Clair D.M., Porteous D.J., Muir W.J. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001, 69:428-433.
9. Booth C.A., Brown J.T., Randall A.D. Neurophysiological modification of CA1 pyramidal neurons in a transgenic mouse expressing a truncated form of disrupted-in-schizophrenia 1. Eur J Neurosci 2014, 39:1074-1090.
10. Brandon N.J., Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nature Rev Neurosci 2011, 12:707-722.
11. Brown S.M., Clapcote S.J., Millar J.K., Torrance H.S., Anderson S.M., Walker R., Rampino A., Roder J.C., Thomson P.A., Porteous D.J., Evans K.L. Synaptic modulators Nrxn1 and Nrxn3 are disregulated in a Disc1 mouse model of schizophrenia. Mol Psychiatry 2011, 16:585-587.
12. Cash-Padgett T., Jaaro-Peled H. DISC1 mouse models as a tool to decipher gene-environment interactions in psychiatric disorders. Frontiers Behav Neurosci 2013, 7:113.
13. Clapcote S.J., Lipina T.V., Millar J.K., Mackie S., Christie S., Ogawa F., Lerch J.P., Trimble K., Uchiyama M., Sakuraba Y., Kaneda H., Shiroishi T., Houslay M.D., Henkelman R.M., Sled J.G., Gondo Y., Porteous D.J., Roder J.C. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007, 54:387-402.
14. Cross-Disorder Group of the Psychiatric Genomics Consortium Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013, 45:984-994.
15. Cuthbert B.N., Insel T.R. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013, 11:126.
16. Dawson N., Kurihara M., Thomson D.M., Winchester C.L., McVie A., Hedde J.R., Randall A.D., Shen S., Seymour P.A., Hughes Z.A., Dunlop J., Brown J.T., Brandon N.J., Morris B.J., Pratt J.A. Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1. Transl Psychiatry 2015, 5:e569.
17. Deco G., Kringelbach M.L. Great expectations: using whole-brain computational connectomics for understanding neuropsychiatric disorders. Neuron 2014, 84:892-905.
18. Dolan B.M., Duron S.G., Campbell D.A., Vollrath B., Shankaranarayana Rao B.S., Ko H.Y., Lin G.G., Govindarajan A., Choi S.Y., Tonegawa S. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proc Natl Acad Sci U S A 2013, 110:5671-5676.
19. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., Carrera N., Humphreys I., Johnson J.S., Roussos P., Barker D.D., Banks E., Milanova V., Grant S.G., Hannon E., Rose S.A., Chambert K., Mahajan M., Scolnick E.M., Moran J.L., Kirov G., Palotie A., McCarroll S.A., Holmans P., Sklar P., Owen M.J., Purcell S.M., O'Donovan M.C. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506:179-184.
20. Greenhill S.D., Juczewski K., de Haan A.M., Seaton G., Fox K., Hardingham N.R. Adult cortical plasticity depends on an early postnatal critical period. Science 2015, 349:424-427.
21. Haque F.N., Lipina T.V., Roder J.C., Wong A.H. Social defeat interacts with Disc1 mutations in the mouse to affect behavior. Behav Brain Res 2012, 233:337-344.
22. Hayashi-Takagi A., Takaki M., Graziane N., Seshadri S., Murdoch H., Dunlop A.J., Makino Y., Seshadri A.J., Ishizuka K., Srivastava D.P., Xie Z., Baraban J.M., Houslay M.D., Tomoda T., Brandon N.J., Kamiya A., Yan Z., Penzes P., Sawa A. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nature Neurosci 2010, 13:327-332.
23. Hayashi-Takagi A., Araki Y., Nakamura M., Vollrath B., Duron S.G., Yan Z., Kasai H., Huganir R.L., Campbell D.A., Sawa A. PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence. Proc Natl Acad Sci U S A 2014, 111:6461-6466.
24. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005, 330:11.
25. Hikida T., Jaaro-Peled H., Seshadri S., Oishi K., Hookway C., Kong S., Wu D., Xue R., Andrade M., Tankou S., Mori S., Gallagher M., Ishizuka K., Pletnikov M., Kida S., Sawa A. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci U S A 2007, 104:14501-14506.
26. Hikida T., Gamo N.J., Sawa A. DISC1 as a therapeutic target for mental illnesses. Expert Opin Ther Targets 2012, 16:1151-1160.
27. Huang J., Perlis R.H., Lee P.H., Rush A.J., Fava M., Sachs G.S., Lieberman J., Hamilton S.P., Sullivan P., Sklar P., Purcell S., Smoller J.W. Cross-disorder genome-wide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry 2010, 167:1254-1263.
28. Ibi D., Nagai T., Koike H., Kitahara Y., Mizoguchi H., Niwa M., Jaaro-Peled H., Nitta A., Yoneda Y., Nabeshima T., Sawa A., Yamada K. Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Behav Brain Res 2010, 206:32-37.
29. Insel T.R. The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry. Am J Psychiatry 2014, 171:395-397.
30. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., Sanislow C., Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010, 167:748-751.
31. Ishizuka K., Kamiya A., Oh E.C., Kanki H., Seshadri S., Robinson J.F., Murdoch H., Dunlop A.J., Kubo K., Furukori K., Huang B., Zeledon M., Hayashi-Takagi A., Okano H., Nakajima K., Houslay M.D., Katsanis N., Sawa A. DISC1-dependent switch from progenitor proliferation to migration in the developing cortex. Nature 2011, 473:92-96.
32. Jaaro-Peled H., Niwa M., Foss C.A., Murai R., de Los Reyes S., Kamiya A., Mateo Y., O'Donnell P., Cascella N.G., Nabeshima T., Guilarte T.R., Pomper M.G., Sawa A. Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging. Hum Mol Genet 2013, 22:1574-1580.
33. Ji B., Higa K.K., Kim M., Zhou L., Young J.W., Geyer M.A., Zhou X. Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders. Hum Mol Genet 2014, 23:5683-5705.
34. Ji B., Kim M., Higa K.K., Zhou X. Boymaw, overexpressed in brains with major psychiatric disorders, may encode a small protein to inhibit mitochondrial function and protein translation. Am J Med Genet B Neuropsychiatr Genet 2015, 168B:284-295.
35. Johnson A.W., Jaaro-Peled H., Shahani N., Sedlak T.W., Zoubovsky S., Burruss D., Emiliani F., Sawa A., Gallagher M. Cognitive and motivational deficits together with prefrontal oxidative stress in a mouse model for neuropsychiatric illness. Proc Natl Acad Sci U S A 2013, 110:12462-12467.
36. Juan L.W., Liao C.C., Lai W.S., Chang C.Y., Pei J.C., Wong W.R., Liu C.M., Hwu H.G., Lee L.J. Phenotypic characterization of C57BL/6J mice carrying the Disc1 gene from the 129S6/SvEv strain. Brain Structure & Function 2014, 219:1417-1431.
37. Kaminitz A., Barzilay R., Segal H., Taler M., Offen D., Gil-Ad I., Mechoulam R., Weizman A. Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression. World J Biol Psychiatry 2014, 15:76-82.
38. Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., Sawamura N., Park U., Kudo C., Okawa M., Ross C.A., Hatten M.E., Nakajima K., Sawa A. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 2005, 7:1167-1178.
39. Katsel P., Tan W., Abazyan B., Davis K.L., Ross C., Pletnikov M.V., Haroutunian V. Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes. Schizophr Res 2011, 130:238-249.
40. Kim J., Horti A.G., Mathews W.B., Pogorelov V., Valentine H., Brasic J.R., Holt D.P., Ravert H.T., Dannals R.F., Zhou L., Jedynak B., Kamiya A., Pletnikov M.V., Wong D.F. Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice. Mol Imaging Biol 2015, 17:355-363.
41. Koike H., Arguello P.A., Kvajo M., Karayiorgou M., Gogos J.A. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc Natl Acad Sci U S A 2006, 103:3693-3697.
42. Kranz T.M., Harroch S., Manor O., Lichtenberg P., Friedlander Y., Seandel M., Harkavy-Friedman J., Walsh-Messinger J., Dolgalev I., Heguy A., Chao M.V., Malaspina D. De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample. Schizophr Res 2015, 166:119-124.
43. Krüger L., Mandelkow E.M. Tau neurotoxicity and rescue in animal models of human Tauopathies. Curr Opin Neurobiol 2015, 36:52-58.
44. Kuroda K., Yamada S., Tanaka M., Iizuka M., Yano H., Mori D., Tsuboi D., Nishioka T., Namba T., Iizuka Y., Kubota S., Nagai T., Ibi D., Wang R., Enomoto A., Isotani-Sakakibara M., Asai N., Kimura K., Kiyonari H., Abe T., Mizoguchi A., Sokabe M., Takahashi M., Yamada K., Kaibuchi K. Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse. Hum Mol Genet 2011, 20:4666-4683.
45. Kvajo M., McKellar H., Arguello P.A., Drew L.J., Moore H., MacDermott A.B., Karayiorgou M., Gogos J.A. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc Natl Acad Sci U S A 2008, 105:7076-7081.
46. Kvajo M., McKellar H., Drew L.J., Lepagnol-Bestel A.M., Xiao L., Levy R.J., Blazeski R., Arguello P.A., Lacefield C.O., Mason C.A., Simonneau M., O'Donnell J.M., MacDermott A.B., Karayiorgou M., Gogos J.A. Altered axonal targeting and short-term plasticity in the hippocampus of Disc1 mutant mice. Proc Natl Acad Sci U S A 2011, 108:E1349-1358.
47. Landek-Salgado M.A., Faust T.E. Sawa A (2015) Molecular substrates of schizophrenia: homeostatic signaling to connectivity. Mol Psychiatry advance online publication September 2015, 22. 10.1038/mp.2015.141.
48. Lee F.H., Fadel M.P., Preston-Maher K., Cordes S.P., Clapcote S.J., Price D.J., Roder J.C., Wong A.H. Disc1 point mutations in mice affect development of the cerebral cortex. J Neurosci 2011, 31:3197-3206.
49. Lee F.H., Kaidanovich-Beilin O., Roder J.C., Woodgett J.R., Wong A.H. Genetic inactivation of GSK3alpha rescues spine deficits in Disc1-L100P mutant mice. Schizophr Res 2011, 129:74-79.
50. Lee K.W., Woon P.S., Teo Y.Y., Sim K. Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt?. Neurosci Biobehav Rev 2012, 36:556-571.
51. Lee F.H., Zai C.C., Cordes S.P., Roder J.C., Wong A.H. Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice. Mol Brain 2013, 6:20.
52. Leliveld S.R., Bader V., Hendriks P., Prikulis I., Sajnani G., Requena J.R., Korth C. Insolubility of disrupted-in-schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease. J Neurosci 2008, 28:3839-3845.
53. Lepagnol-Bestel A.M., Kvajo M., Karayiorgou M., Simonneau M., Gogos J.A. A Disc1 mutation differentially affects neurites and spines in hippocampal and cortical neurons. Mol Cell Neurosci 2013, 54:84-92.
54. Li W., Zhou Y., Jentsch J.D., Brown R.A., Tian X., Ehninger D., Hennah W., Peltonen L., Lonnqvist J., Huttunen M.O., Kaprio J., Trachtenberg J.T., Silva A.J., Cannon T.D. Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U S A 2007, 104:18280-18285.
55. Li N., Zheng J., Li H., Deng J., Hu M., Wu H., Li W., Li F., Lan X., Lu J., Zhou Y. Identification of chimeric TSNAX-DISC1 resulting from intergenic splicing in endometrial carcinoma through high-throughput RNA sequencing. Carcinogenesis 2014, 35:2687-2697.
56. Lipina T.V., Niwa M., Jaaro-Peled H., Fletcher P.J., Seeman P., Sawa A., Roder J.C. Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav 2010, 9:777-789.
57. Lipina T.V., Wang M., Liu F., Roder J.C. Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice. Neuropharmacol 2012, 62:1252-1262.
58. Lipina T.V., Haque F.N., McGirr A., Boutros P.C., Berger T., Mak T.W., Roder J.C., Wong A.H. Prophylactic valproic acid treatment prevents schizophrenia-related behaviour in Disc1-L100P mutant mice. PLoS One 2012, 7:e51562.
59. Lipina T.V., Zai C., Hlousek D., Roder J.C., Wong A.H. Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J Neurosci 2013, 33:7654-7666.
60. Mao Y., Ge X., Frank C.L., Madison J.M., Koehler A.N., Doud M.K., Tassa C., Berry E.M., Soda T., Singh K.K., Biechele T., Petryshen T.L., Moon R.T., Haggarty S.J., Tsai L.H. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009, 136:1017-1031.
61. Mathieson I., Munafò M.R., Flint J. Meta-analysis indicates that common variants at the DISC1 locus are not associated with schizophrenia. Mol Psychiatry 2012, 17:634-641.
62. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., St Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000, 9:1415-1423.
63. Millar J.K., Christie S., Semple C.A., Porteous D.J. Chromosomal location and genomic structure of the human Translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia. Genomics 2000, 67:69-77.
64. Muraki K., Tanigaki K. Neuronal migration abnormalities and its possible implications for schizophrenia. Front Neurosci 2015, 9:74.
65. Nagai T., Kitahara Y., Ibi D., Nabeshima T., Sawa A., Yamada K. Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI: C treatment. Behav Brain Res 2011, 225:305-310.
66. Nakai T., Nagai T., Wang R., Yamada S., Kuroda K., Kaibuchi K., Yamada K. Alterations of GABAergic and dopaminergic systems in mutant mice with disruption of exons 2 and 3 of the Disc1 gene. Neurochem Intl 2014, 74:74-83.
67. Nakata K., Lipska B.K., Hyde T.M., Ye T., Newburn E.N., Morita Y., Vakkalanka R., Barenboim M., Sei Y., Weinberger D.R., Kleinman J.E. DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc Natl Acad Sci U S A 2009, 106:15873-15878.
68. Narayan S., Nakajima K., Sawa A. DISC1: a key lead in studying cortical development and associated brain disorders. Neuroscientist 2013, 19:451-464.
69. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nature Neurosci 2015, 18:199-209.
70. Niwa M., Kamiya A., Murai R., Kubo K., Gruber A.J., Tomita K., Lu L., Tomisato S., Jaaro-Peled H., Seshadri S., Hiyama H., Huang B., Kohda K., Noda Y., O'Donnell P., Nakajima K., Sawa A., Nabeshima T. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 2010, 65:480-489.
71. Niwa M., Jaaro-Peled H., Tankou S., Seshadri S., Hikida T., Matsumoto Y., Cascella N.G., Kano S., Ozaki N., Nabeshima T., Sawa A. Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 2013, 339:335-339.
72. Ottis P., Bader V., Trossbach S.V., Kretzschmar H., Michel M., Leliveld S.R., Korth C. Convergence of two independent mental disease genes on the protein level: recruitment of dysbindin to cell-invasive disrupted-in-schizophrenia 1 aggresomes. Biol Psychiatry 2011, 70:604-610.
73. Owen M.J., Sawa A., Mortensen P.B. Schizophrenia. Lancet 2015, (in press).
74. Park S.J., Jeong J., Park Y.U., Park K.S., Lee H., Lee N., Kim S.M., Kuroda K., Nguyen M.D., Kaibuchi K., Park S.K. Disrupted-in-schizophrenia-1 (DISC1) Regulates Endoplasmic Reticulum Calcium Dynamics. Sci Rep 2015, 5:8694.
75. Piaceri I., Nacmias B., Sorbi S. Genetics of familial and sporadic Alzheimer's disease. Front Biosci 2013, 5:167-177.
76. Pletnikov M.V., Ayhan Y., Nikolskaia O., Xu Y., Ovanesov M.V., Huang H., Mori S., Moran T.H., Ross C.A. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 2008, 13:173-186.
77. Porteous D.J., Millar J.K., Brandon N.J., Sawa A. DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends Mol Med 2011, 17:699-706.
78. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
79. Purcell S.M., Moran J.L., Fromer M., Ruderfer D., Solovieff N., Roussos P., O'Dushlaine C., Chambert K., Bergen S.E., Kähler A., et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014, 506:185-190.
80. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kähler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013, 45:1150-1159.
81. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427.
82. Seshadri S., Kamiya A., Yokota Y., Prikulis I., Kano S., Hayashi-Takagi A., Stanco A., Eom T.Y., Rao S., Ishizuka K., Wong P., Korth C., Anton E.S., Sawa A. Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc Natl Acad Sci U S A 2010, 107:5622-5627.
83. Shahani N., Seshadri S., Jaaro-Peled H., Ishizuka K., Hirota-Tsuyada Y., Wang Q., Koga M., Sedlak T.W., Korth C., Brandon N.J., Kamiya A., Subramaniam S., Tomoda T., Sawa A. DISC1 regulates trafficking and processing of APP and Abeta generation. Mol Psychiatry 2015, 20:874-879.
84. Shen S., Lang B., Nakamoto C., Zhang F., Pu J., Kuan S.L., Chatzi C., He S., Mackie I., Brandon N.J., Marquis K.L., Day M., Hurko O., McCaig C.D., Riedel G., St Clair D. Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J Neurosci 2008, 28:10893-10904.
85. Shoji H., Toyama K., Takamiya Y., Wakana S., Gondo Y., Miyakawa T. Comprehensive behavioral analysis of ENU-induced Disc1-Q31L and -L100P mutant mice. BMC Res Notes 2012, 5:108.
86. Singh K.K., Ge X., Mao Y., Drane L., Meletis K., Samuels B.A., Tsai L.H. Dixdc1 is a critical regulator of DISC1 and embryonic cortical development. Neuron 2010, 67:33-48.
87. Singh K.K., De Rienzo G., Drane L., Mao Y., Flood Z., Madison J., Ferreira M., Bergen S., King C., Sklar P., Sive H., Tsai L.H. Common DISC1 polymorphisms disrupt Wnt/GSK3β signaling and brain development. Neuron 2011, 72:545-558.
88. Su P., Li S., Chen S., Lipina T.V., Wang M., Lai T.K., Lee F.H., Zhang H., Zhai D., Ferguson S.S., Nobrega J.N., Wong A.H., Roder J.C., Fletcher P.J., Liu F. A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects. Neuron 2014, 84:1302-1316.
89. Tsuboi D., Kuroda K., Tanaka M., Namba T., Iizuka Y., Taya S., Shinoda T., Hikita T., Muraoka S., Iizuka M., Nimura A., Mizoguchi A., Shiina N., Sokabe M., Okano H., Mikoshiba K., Kaibuchi K. Disrupted-in-schizophrenia 1 regulates transport of ITPR1 mRNA for synaptic plasticity. Nature Neurosci 2015, 18:698-707.
90. van Os J., Bak M., Hanssen M., Bijl R.V., de Graaf R., Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002, 156:319-327.
91. Wong A.H., Josselyn S.A. Caution when diagnosing your mouse with schizophrenia: the use and misuse of model animals for understanding psychiatric disorders. Biol Psychiatry 2015, (in press).
92. Zhou X., Chen Q., Schaukowitch K., Kelsoe J.R., Geyer M.A. Insoluble DISC1-Boymaw fusion proteins generated by DISC1 translocation. Mol Psychiatry 2010, 15:669-672.